Google’s first-stage retrieval still runs on word matching, not AI magic. Here’s how to use content scoring tools accordingly ...
This article takes a deep dive into the history of proteomics from the conception of the term “proteome” up to modern-day advances in bioinformatics and single-cell protein analysis.
Neither of those issues bodes especially well for the 2026 Audi A6 E-Tron, which happens to be a sedan that’s powered by nothing but electrons. And that’s a shame, because it means a majority of ...
The journey towards circular high-performance composites begins with one core question: why redesign an already mature class of materials? To set the scene, we asked the consortium to describe the ...
Introduction Perinatal depression poses substantial risks to both mothers and their offspring. Given its chronic and ...
Morning Overview on MSN
Tiny supernova mistake might erase the dark energy crisis, study says
A small, seemingly technical assumption baked into the way astronomers standardize Type Ia supernovae may be responsible for the growing tension between different measurements of dark energy. New data ...
The Lightweight Innovations for Tomorrow public-private partnership has drawn a five-year U.S. Dept. of War assignment to “disrupt manufacturing affordability” for ceramic ...
Mitochondria possess their own mRNA translation system, mediated by specialized mitoribosomes. Dysregulation of mitochondrial translation disrupts metabolic homeostasis and is linked to various ...
Compliance is one of the most persistent bottlenecks in regulated software development, often requiring weeks or months of manual documentation after products are built. In this episode of DEMO, Keith ...
Programming is the backbone of modern technology, and understanding a programming languages list is essential for developers, students, and tech enthusiasts. In 2026, Python leads AI and data science ...
Per the terms of the agreement, Novavax will receive an upfront payment of $30 million from Pfizer and is eligible to earn up to $500 million in potential development and commercial milestone payments ...
Novavax has agreed to a deal to let Pfizer use Matrix-M adjuvant in its products for an upfront payment of $30 million and up to another $500 million in milestone payments. The biotech company said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results